biomark
use
year
help
clinic
decisionmak
creactiv
protein
crp
probabl
best
known
marker
use
monitor
infect
although
use
reliabl
distinguish
viral
bacteri
infect
recentlydevelop
marker
procalcitonin
seem
promis
detect
rise
earli
cours
infect
high
neg
predict
valu
seen
children
fever
unknown
origin
van
rossum
et
al
galettolacour
et
al
herd
howev
marker
also
insuffici
power
discrimin
viral
bacteri
infect
addit
convent
biomark
infecti
diseas
provid
microorganismspecif
prognost
inform
complet
human
genom
project
introduct
power
dna
microarray
chip
proteom
technolog
creat
opportun
identifi
gene
protein
may
serv
biomark
infecti
diseas
identif
biomark
may
enabl
develop
excit
potenti
clinic
applic
gene
protein
differenti
express
healthi
infect
individu
investig
intern
hapmap
project
approach
may
provid
detail
insight
pathogenesi
diseas
host
pathogen
interact
diseasespecif
express
pattern
addit
diagnost
prognost
biomark
marker
monitor
diseas
respons
therapi
may
develop
use
technolog
chapter
describ
recent
advanc
genom
proteom
field
biomark
infecti
diseas
summar
current
clinic
applic
futur
perspect
singl
nucleotid
polymorph
snp
singl
base
pair
chang
specif
spot
genom
common
type
genet
variat
human
genom
carri
million
nucleotid
vari
least
popul
current
approxim
million
nucleotid
valid
number
still
grow
bryant
et
al
walker
siminovitch
although
snp
chang
frequent
explor
use
high
throughput
technolog
genet
variat
also
common
human
genom
may
influenc
individu
suscept
diseas
includ
variat
gene
copi
number
repeat
sequenc
motif
insert
delet
crawford
et
al
complet
human
genom
map
combin
develop
microarraybas
compar
genom
hybrid
genomewid
snp
platform
permit
screen
entir
genom
identifi
genet
loci
link
certain
diseas
suscept
diseas
respons
therapi
feuk
et
al
genom
wide
associ
studi
allow
identif
genet
risk
factor
wide
varieti
common
complex
diseas
measur
hundr
thousand
genet
variant
simultan
use
snp
platform
malariagen
genom
epidemiolog
network
wellcom
trust
casecontrol
consortium
wtccc
perform
larg
scale
studi
diseas
suscept
consortia
analyz
snp
thousand
african
individu
diagnos
malaria
tuberculosi
addit
wtccc
includ
approxim
case
control
diseas
make
one
biggest
project
aim
identif
genet
variat
may
predispos
patient
diseas
genomewid
associ
studi
genomewid
analys
may
contribut
identif
individu
risk
produc
effect
prevent
strategi
individu
treatment
strategi
genom
provid
inform
genet
suscept
certain
infecti
diseas
transcriptom
provid
inform
activ
gene
certain
moment
certain
condit
studi
complet
set
rna
transcript
produc
genom
biolog
process
part
genom
specif
transcrib
messeng
rna
mrna
transcriptom
translat
protein
proteom
transcriptom
analyz
use
gene
express
microarray
chip
contain
either
whole
genom
subset
specif
gene
mrna
extract
experiment
sampl
revers
transcrib
label
fluoresc
dye
extract
label
cdna
hybrid
microarray
fluoresc
array
determin
use
array
scanner
follow
imag
analysi
data
subject
bioinformat
process
identifi
statist
signific
chang
gene
express
differ
sampl
techniqu
use
character
gene
express
pathogen
host
provid
detail
insight
hostpathogen
interact
infect
liu
et
al
studi
molecular
level
kawada
et
al
gener
geneexpress
profil
peripher
blood
mononuclear
cell
pbmc
isol
children
influenza
viru
infect
mani
gene
associ
immun
respons
interferon
regul
gene
appear
strongli
upregul
influenza
infect
addit
compar
gene
express
profil
influenzainfect
children
without
convuls
found
transcript
level
proinflammatori
cytokin
gene
patient
febril
convuls
significantli
differ
patient
without
febril
convuls
kind
approach
may
help
clarifi
pathogenesi
influenza
neurolog
complic
kawada
et
al
gene
express
profil
may
complet
correl
intracellular
protein
content
proteom
provid
insight
structur
dynam
end
product
protein
proteom
studi
proteom
complet
set
protein
modif
interact
local
proteom
technolog
enabl
detail
analys
protein
express
evalu
posttransl
modif
protein
stabil
turnov
assess
genom
transcriptom
profil
alon
mani
year
twodimension
gel
electrophoresi
standard
technolog
isol
specif
protein
allow
protein
identif
subsequ
mass
spectrometri
past
decad
mass
spectrometri
improv
enabl
analysi
protein
express
structur
function
without
need
labor
intens
time
consum
electrophoresi
grave
haystead
patterson
aebersold
addit
sever
mass
spectrometrybas
approach
develop
allow
rel
absolut
quantif
protein
attempt
identifi
biomark
develop
screen
tool
high
sensit
specif
proteom
technolog
appli
analyz
biofluid
serum
saliva
urin
commonli
use
techniqu
surfac
enhanc
laser
desorptionion
timeofflight
selditof
proteom
techniqu
allow
identif
larg
number
protein
short
period
time
techniqu
provid
specif
mass
spectral
profil
analyz
protein
sampl
compar
profil
affect
individu
deriv
healthi
control
specif
protein
signatur
obtain
coomb
et
al
hodgett
et
al
agranoff
colleagu
use
characteris
distinct
profil
sever
microbi
infect
investig
serum
respons
tuberculosi
identifi
serum
biomark
patient
advanc
tuberculosi
selditof
potenti
identifi
tuberculosi
earli
stage
assist
earli
diagnosi
therapi
import
favor
outcom
agranoff
et
al
recent
advanc
proteom
genom
technolog
allow
identif
gene
protein
may
serv
biomark
diagnosi
monitor
infecti
diseas
applic
knowledg
technolog
clinic
practic
still
earli
stage
follow
section
first
discuss
current
literatur
contribut
aforement
technolog
determin
diseas
pathogenesi
suscept
infect
diagnost
next
section
discuss
clinic
applic
proteom
transcriptom
technolog
last
section
focu
futur
perspect
increas
use
genom
proteom
technolog
insight
obtain
hostpathogen
interact
pathogenesi
infecti
diseas
respons
host
pathogen
reflect
chang
gene
express
measur
microarray
base
gene
express
technolog
likewis
transcript
profil
studi
proven
power
approach
analyz
understand
hostpathogen
interact
base
upon
host
respons
variou
pathogen
jenner
et
al
identifi
common
specif
gene
express
pattern
collect
systemat
compar
transcript
profil
dataset
publish
microarraybas
vitro
studi
collect
examin
differ
hostpathogen
interact
respons
wide
varieti
pathogen
identifi
cluster
gene
share
common
respons
upon
infect
pathogen
accord
local
cell
function
gene
cluster
differ
function
group
order
provid
overview
cellular
physiolog
involv
common
host
respons
moreov
analyz
differ
transcript
profil
studi
also
reveal
pathogen
specif
gene
express
pattern
sever
host
gene
aforement
common
host
respons
found
downregul
presenc
pathogen
specif
pathogen
protein
transcript
profil
studi
provid
insight
microorgan
alter
host
gene
express
pattern
subvert
immun
respons
exampl
transcript
profil
identifi
virus
herp
simplex
viru
hsv
human
cytomegaloviru
human
partial
complet
abl
inhibit
induct
interferon
stimul
gene
central
role
defens
virus
jenner
young
streptococcu
pneumonia
influenza
viru
common
caus
pneumonia
consequ
contribut
substanti
morbid
mortal
worldwid
known
year
influenza
infect
predispos
secondari
bacteri
infect
mainli
caus
pneumonia
aureu
catastroph
influenza
pandem
approxim
million
person
kill
may
involv
synergi
influenza
pneumococc
infect
gene
express
profil
power
tool
explor
molecular
mechan
synergi
pathogen
host
gene
express
analys
lung
mice
rousseau
et
al
differenti
pneumococc
infect
influenza
rosseau
et
al
also
identifi
common
gene
express
pattern
infecti
diseas
well
uniqu
pathogenspecif
gene
express
signatur
may
help
clarifi
mechan
behind
synergi
influenza
viru
pneumonia
rosseau
et
al
respons
influenza
infect
tong
et
al
perform
gene
express
analys
middl
ear
epitheli
cell
tong
et
al
tong
et
al
suggest
increas
express
inflammatori
mediat
gene
could
lead
shift
pneumonia
adher
activ
host
epitheli
endotheli
cell
provid
favor
environ
middl
ear
caviti
secondari
bacteri
infect
pneumonia
respons
upon
exposur
pathogen
vari
wide
individu
peopl
suscept
certain
infect
other
differenti
suscept
partli
caus
genet
variat
individu
may
predispos
either
develop
diseas
sever
cours
although
larg
variat
clinic
respons
among
individu
also
depend
upon
environment
microbi
factor
classic
exampl
host
genet
suscept
resist
heterozyg
hemoglobin
individu
malaria
infect
caus
plasmodium
falciparum
allison
approach
use
elucid
genet
environment
effect
infect
includ
studi
ident
nonident
twin
hill
jepson
et
al
jepson
et
al
comparison
risk
adopt
children
biolog
adopt
parent
one
studi
suggest
adopt
children
biolog
parent
die
earli
infecti
diseas
higher
risk
mortal
similar
infect
death
adopt
parent
due
infect
influenc
risk
diseas
children
sorensen
et
al
recent
advanc
microarray
technolog
enabl
genom
wide
search
gene
influenc
suscept
infecti
diseas
analysi
genet
suscept
aim
link
genet
code
genotyp
risk
certain
diseas
state
phenotyp
given
larg
number
human
gene
mani
unknown
function
genom
wide
studi
advantag
previous
unconsid
gene
identifi
provid
sensit
detect
subtl
genet
effect
gene
recruit
affect
individu
howev
mani
report
genet
associ
replic
subsequ
studi
secur
result
larg
number
affect
unaffect
individu
requir
furthermor
complex
data
analysi
microarray
technolog
time
labor
intens
xavier
rioux
cook
hill
hirschhorn
dali
nevertheless
sever
larg
scale
popul
base
studi
perform
support
role
genom
wide
search
identif
gene
influenc
diseas
suscept
wtccc
obrien
nelson
et
al
hill
exampl
genet
associ
studi
perform
obrien
et
al
led
identif
variou
genet
factor
affect
genet
associ
analysi
sever
larg
cohort
hiv
infect
individu
result
identif
aid
restrict
gene
human
gene
polymorph
variant
influenc
outcom
exposur
infect
studi
obrien
et
al
illustr
discoveri
previous
unknown
gene
involv
suscept
infect
use
snp
haplotypebas
associ
studi
clinic
welldescrib
epidemiolog
cohort
obrien
nelson
anoth
potenti
applic
microarray
technolog
diagnosi
infect
direct
indirect
identif
pathogen
exampl
microarray
compos
dna
sequenc
variou
pathogen
allow
identif
mani
organ
singl
test
wang
et
al
develop
array
compos
fulli
sequenc
refer
viral
genom
allow
detect
approxim
virus
wang
et
al
moreov
sequenc
hybrid
materi
unknown
pathogen
array
permit
identif
new
virus
prove
success
global
effort
identifi
novel
corona
viru
associ
sever
acut
respiratori
syndrom
sar
wang
et
al
ksiazek
et
al
contrast
direct
identif
infect
also
characteris
indirectli
specif
host
respons
advantag
pathogenspecif
molecular
signatur
host
may
present
variou
stage
infect
even
pathogen
detect
use
standard
direct
diagnost
test
ramilo
et
al
use
gene
express
analysi
diagnos
differ
pathogen
fingerprint
pediatr
patient
respiratori
infect
caus
influenza
viru
gramneg
ecoli
gramposit
staphylococcu
aureu
streptococcu
pneumonia
bacteria
classifi
gene
discrimin
influenza
bacteri
infect
pneumonia
aureu
e
coli
aureu
infect
identifi
valid
anoth
exampl
omic
technolog
use
diagnos
infect
develop
protein
base
signatur
diagnos
trypanosomiasi
sleep
sick
affect
half
million
peopl
yearli
subsaharan
africa
trypanosomiasi
left
untreat
debilit
diseas
lethaloutcom
success
control
past
sinc
reemerg
epidem
immens
proport
caus
huge
yet
wide
underestim
morbid
mortal
case
everi
year
stich
et
al
establish
diagnosi
remain
complic
current
diagnost
test
lack
sensit
detect
low
parasit
load
peripher
blood
papadopoulo
et
al
analyz
serum
sampl
patient
control
use
seldi
tof
mass
spectrometri
identifi
distinct
serum
proteom
signatur
group
papadopoulo
et
al
deplet
serum
sampl
antibodi
compon
author
identifi
two
promin
protein
peak
kda
patient
proteom
signatur
may
provid
basi
new
diagnost
test
altern
method
monitor
host
respons
treatment
moreov
addit
character
differenti
express
protein
may
allow
develop
simpler
cheaper
antibodi
base
test
papadopoulo
et
al
agranoff
et
al
children
admit
hospit
fever
nonspecif
symptom
relat
infect
schaad
although
necessarili
suffer
bacteri
infect
signific
proport
children
receiv
antibiot
although
clinic
histori
physic
examin
convent
diagnost
investig
eg
xray
blood
test
may
point
extent
toward
caus
pathogen
identif
remain
difficult
even
imposs
episod
acut
fever
clinician
prefer
reli
cultur
taken
site
infect
howev
cultur
often
obtain
right
time
relev
site
eg
middl
ear
lung
result
avail
least
h
sampl
pathogen
often
remain
undetect
furthermor
contamin
colon
particularli
upper
airway
sampl
obscur
result
gene
express
profil
may
identifi
bacteri
pathogen
discrimin
bacteri
infect
infect
caus
pathogen
noninfecti
caus
fever
like
autoinflammatori
diseas
use
microarray
organ
identifi
either
directli
indirectli
effect
host
gene
express
tang
et
al
show
gene
express
profil
neutrophil
distinguish
sepsi
noninfecti
inflamm
eg
systemat
inflammatori
respons
syndrom
sir
intens
care
patient
perform
microarray
cohort
septic
nonsept
patient
identifi
classifi
gene
differenti
express
two
group
involv
inflammatori
respons
immun
regul
mitochondri
function
broadli
gene
involv
upregul
immun
respons
express
less
patient
sepsi
control
patient
wherea
gene
involv
regul
express
suggest
sepsi
may
inhibitori
effect
immun
regul
pathway
analys
support
find
immun
regul
inhibit
sepsi
show
gene
involv
nfb
pathway
express
less
patient
sepsi
wherea
inhibitori
gene
nfkbia
express
predict
model
diseas
sever
develop
data
valid
second
heterogen
patient
group
tang
et
al
major
advantag
gene
express
profil
may
enabl
develop
less
expens
diagnost
tool
quantit
real
timepolymeras
chain
reaction
rtpcr
detect
quantif
specif
dna
sequenc
septic
patient
instead
entir
gene
express
profil
children
autoinflammatori
diseas
often
present
nonspecif
system
symptom
like
rash
fever
preced
specif
symptom
like
arthriti
diagnosi
inflammatori
diseas
often
difficult
due
present
nonspecif
symptom
low
incid
diseas
patient
often
empir
treat
like
caus
symptom
includ
infect
delay
diagnosi
initi
appropri
treatment
suboptim
child
may
also
result
misus
antibiot
contribut
emerg
antibiot
resist
differenti
patient
autoinflammatori
diseas
eg
system
onset
juvenil
idiopath
arthriti
patient
acut
viral
bacteri
infect
allantez
et
al
analyz
leukocyt
gene
express
profil
differ
blood
leukocyt
subpopul
obtain
patient
base
result
specif
blood
signatur
develop
enabl
differenti
infect
febril
inflammatori
diseas
allantaz
et
al
along
permit
character
infect
pathogen
directli
detect
measur
specif
gene
express
host
potenti
permit
distinct
colon
infect
pathogen
microorgan
exampl
bacteri
secondari
infect
children
primari
viral
lower
respiratori
tract
infect
often
diagnos
base
cultur
upper
airway
sampl
question
remain
whether
detect
organ
realli
caus
infect
whether
contamin
upper
airway
jacob
dagan
develop
diagnost
test
base
gene
express
pattern
host
may
provid
specif
inform
futur
develop
diagnost
tool
may
help
clinician
choos
effect
treatment
strategi
reduc
inappropri
antibiot
use
diagnost
delay
infecti
diseas
lead
delay
initi
therapi
sever
complic
long
term
consequ
may
includ
death
delay
diagnosi
may
prevent
develop
diagnost
biomark
enceph
exampl
complex
sever
neurolog
syndrom
associ
signific
morbid
mortal
character
inflamm
brain
parenchyma
children
often
present
drowsi
fever
headach
seizur
focal
neurolog
sign
delay
treatment
may
lead
irrevers
brain
damag
diagnosi
often
presumpt
base
clinic
characterist
increas
serolog
antibodi
titer
unfortun
caus
pathogen
often
hard
detect
central
nervou
system
final
diagnosi
sometim
base
detect
pathogen
cultur
site
respiratori
tract
glaser
et
al
indirectli
diagnos
enceph
base
respiratori
sampl
rather
inaccur
demonstr
need
new
better
diagnost
tool
new
microarray
proteom
technolog
may
contribut
improv
diagnosi
treatment
microarray
develop
simultan
identifi
differ
viral
bacteri
pathogen
cerebrospin
fluid
csf
boriskin
et
al
ben
et
al
knowledg
gene
express
studi
differenti
pathogen
base
host
respons
yet
perform
differenti
pathogen
base
host
respons
may
provid
better
insight
pathogenesi
diseas
specif
profil
blood
cerebrospin
fluid
may
also
prove
use
diagnos
enceph
identif
biomark
relat
clinic
profil
recognit
subgroup
enceph
may
help
predict
outcom
provid
insight
efficaci
therapi
anoth
infect
diagnost
difficulti
often
lead
delay
appropri
therapi
infect
endocard
clinic
diagnosi
infect
endocard
may
difficult
fever
symptom
rapid
diagnosi
follow
appropri
treatment
critic
import
surviv
howev
patient
caus
pathogen
remain
undetect
fenollar
et
al
analyz
serum
sampl
patient
clinic
suspicion
endocard
identifi
differ
protein
peak
patient
confirm
endocard
compar
diagnosi
exclud
fenollar
et
al
develop
diagnost
assay
base
protein
peak
despit
limit
number
differenti
express
protein
test
still
abl
classifi
major
patient
correctli
proteom
genom
technolog
shown
contribut
improv
insight
diseas
pathogenesi
may
use
diagnos
infect
provid
inform
diseas
suscept
howev
clinic
applic
technolog
yet
develop
futur
research
focu
valid
previous
identifi
biomark
well
develop
new
diagnost
assay
relationship
gene
express
profil
diseas
outcom
anoth
interest
field
research
prognost
biomark
could
import
infecti
diseas
help
predict
like
diseas
cours
select
patient
like
benefit
treatment
present
clinic
use
limit
field
cancer
research
sever
studi
suggest
molecular
classif
tumor
base
gene
express
may
identifi
distinct
prognost
subtyp
alizedah
et
al
detect
two
subtyp
diffus
bcell
lymphoma
differ
surviv
pattern
alizadeh
et
al
mamma
print
test
develop
dutch
cancer
institut
identifi
differ
breast
cancer
subtyp
analysi
express
profil
involv
gene
indic
poor
prognosi
va
nt
veer
et
al
va
nt
veer
bernard
studi
base
hierarch
cluster
subgroup
similar
gene
express
profil
hierarch
cluster
method
gene
express
analys
might
prove
use
pediatr
infecti
diseas
although
date
studi
done
chaussabel
et
al
gener
potenti
use
framework
visual
function
interpret
microarray
base
diseasespecif
transcript
signatur
chaussabel
et
al
addit
identif
biomark
monitor
inflammatori
diseas
activ
sle
show
potenti
valu
evalu
diseas
progress
thu
prognosi
chaussabel
et
al
depart
current
conduct
clinic
studi
identifi
classifi
gene
predict
outcom
children
suffer
lower
respiratori
tract
viral
infect
virgo
studi
use
microarray
analys
blood
leukocyt
respiratori
sampl
aim
identifi
biomark
distinguish
children
rel
mild
cours
diseas
deterior
requir
supplement
oxygen
mechan
ventil
earli
phase
infect
biomark
may
help
decid
whether
child
need
hospit
anoth
potenti
applic
guid
treatment
allow
therapi
tailor
specif
pathogen
includ
antimicrobi
resist
properti
host
characterist
includ
immun
respons
lead
focus
drug
use
improv
outcom
earli
exampl
genotypeguid
individu
treatment
strategi
adjust
isoniazid
dose
regimen
adult
tuberculosi
nacetyltransferas
type
play
import
role
isoniazid
metabol
genet
polymorph
enzym
alter
respons
drug
determin
genotyp
prior
isoniazid
administr
predict
pharmacokinet
variabl
therapeut
respons
kinzigschipp
et
al
individu
treatment
strategi
extrem
help
treat
tuberculosi
children
present
children
tuberculosi
treat
four
tuberculostat
agent
two
month
follow
two
drug
regimen
month
continu
phase
date
laboratori
tool
monitor
respons
therapi
moreov
difficulti
identif
tuberculosi
exampl
induc
sputum
gastric
lavag
contribut
diagnost
therapeut
uncertainti
newton
et
al
consequ
nonspecif
clinic
featur
symptom
improv
weight
gain
radiolog
featur
chest
diseas
use
marker
therapeut
respons
donald
schaff
identif
biomark
tuberculosi
diseas
activ
may
provid
specif
monitor
strategi
lead
focus
prescrib
fewer
advers
effect
less
multidrug
resist
diagnost
uncertainti
infecti
diseas
may
lead
delay
diagnosi
inappropri
use
antibiot
develop
diagnost
biomark
infecti
diseas
may
result
rapid
diagnosi
reliabl
discrimin
infect
noninfecti
diseas
improv
manag
better
cours
outcom
less
inappropri
use
antibiot
microarray
proteom
technolog
begin
contribut
improv
understand
pathogenesi
wide
varieti
infecti
diseas
great
prospect
futur
technolog
target
direct
pathogen
detect
character
host
respons
may
also
assist
diagnosi
diseas
monitor
well
predict
individu
suscept
diseas
respons
medic
therapi
overal
prognosi
although
promis
clinic
applic
technolog
infecti
diseas
limit
present
current
research
focus
sophist
highli
special
techniqu
futur
work
need
direct
clinic
valid
studi
collect
data
clinic
applic
accuraci
cost
effect
translat
biomark
research
clinic
use
test
difficult
time
labor
intens
ultim
goal
develop
clinic
relev
cheap
rapid
diagnost
prognost
biomark
test
use
biolog
sampl
easi
obtain
patient
gener
reliabl
easili
interpret
result
